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It is a great honour to be asked to give the Scott-
Heron Lecture at the Royal Victoria Hospital.
The list of lecturers since the first in 1957
comprisesaformidablecatalogueofdistinguished
medicalnamesfromallovertheworld.Iremember
as a medical student hearing the first lecture, on
Smallpox in Ireland, by Sir William McArthur
who was renowned for his remarkable visual
memory and who gave his talk without notes.
Little did I think that I might find myself in the
samepositionover40yearslater. Iamparticularly
honoured to be only the fifth serving member of
the Royal Victoria Hospital staffto be invited to
give this lecture.
The topic, Hyperglycaemia and Adverse
PregnancyOutcome, (HAPO)representsthestory
of my research interests over those 40 years,
which range across a number of clinical
boundaries including endocrinology, medical
obstetrics, nutritionalpaediatrics andagreatdeal
of epidemiology. The lecture was endowed by
thegenerosityofDrFrancis HughScottwhodied
in 1946. Hehadpractisedas afamilydoctorinthe
district dispensary in Saintfield, County Down,
where he was the predecessor of the present Dr
James McKelvey's father. Dr James McKelvey
himself remembers as a small boy meeting Dr
Scott and being very impressed by his large
motor-car. Dr Scott lived in a house in the Main
StreetinSaintfield as abachelor, with amaidand
a chauffeur who drove the big white car. The
houseisstillthereintheMainStreet; nowpainted
a rather dark brown colour, just opposite the
parishchurch(Fig. 1). DrScotthadadistinguished
undergraduate career, winning the Malcolm
Exhibition at the Belfast Royal Hospital and the
gold medal at the Ulster Hospital for Children
and Women. He qualified in 1891 by passing the
Fig 1. Saintfield Main Street, December 2000.
ScottishTripleConjointDiplomawhichwasoften
taken by Belfast medical students at that time as
the trip to Dublin to sit the MB BCh BAO
examination of the Royal University of Ireland
was considered more difficult and passing less
assured. Also the triple qualification, although
not a University degree, looked most impressive
on a professional plate - LRCPEd, LRCSEd,
LRFPS Glas. Aftergeneralpractice forawhile in
the south of England he was appointed to the
districtdispensaryinSaintfieldandworkedthere
for the rest of his professional career. When he
died in 1946, he left a legacy of £3,000 to the
RoyalVictoriaHospitalforeducationalpurposes.
By careful investment this legacy has increased
considerably in value and is maintained inboth a
capital and a revenue account under the
supervision oftheChairman oftheMedical Staff
Committee. Dr Scott was buried in his mother's
familymausoleuminKillyleaghChurchyard, the
Heron family being long established in County
Down. OneoftheearlyHeronswasajointfounder
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of the Ulster Bank, and a major donation to this
hospital by another Heron enabled the top floor
of 'A' Blocktobebuiltwhenitwasknown asthe
HeronClinicforprivatepatients.Majordonations
andlegacies fromwealthy families are still made
to this hospital, but not any longer to the general
funds of the hospital and often these donations
areearmarkedforaparticulardiseaseorspecialty.
ThishasmadethecontinuedfundingoftheRoyal
Victoria Hospital Clinical Research Fellowships
increasingly difficult over the past number of
years as these Fellowships have been funded
from the general undefined Trust Funds of the
hospital, and with the recent fall in financial
interest rates the funds available for Clinical
Research Fellowships have become severely
limited.
WHERE ARE WE COMING FROM?
The HAPO Hypothesis states that
"hyperglycaemia in pregnancy less severe than
overt diabetes mellitus is associated with
increased risk of adverse maternal, fetal and
neonatal outcomes that is independently related
to the degree ofmetabolic disturbance".
The story begins with Dr Heinrich Bennewitz in
1823 at the Charite Hospital in Berlin' who was
responsible for the delivery of a 12 lb baby to a
patient who had developed thirst and polyuria in
herpregnancy(Fig.2).Therewasnomeasurement
ofblood glucose at that time, but he was able to
demonstrate the presence of large quantities of
sugar in her urine by the simple expedient of
boiling this up in a saucepan and producing a
treacle-like substancewhichhecarefullyweighed.
Theoutcome ofthepregnancy was notgood. The
baby diedbecause ofobstruction duringdelivery
because it was so large. Dr Bennewitz wrote the
case up as his thesis for the degree of doctor of
medicine at the University of Berlin, but no
further documentation either of his career or of
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Fig 2. Charite Hospital, Berlin (1785-1800).
Fig 3. DrAndrewMalcolm(1856)fProfessorJALindsay
(1923).
the future outcome ofthe motherhas been found.
Thethesis, inLatin, was discoveredin an archive
in Germany in 1986, and was translated into
English attheDepartmentofLatin attheQueen's
University ofBelfast. Diabetes in thosedays was
considered a relatively unusual diagnosis, and
this was the first record ofgestational diabetes.
Thirty years later, Dr Andrew Malcolm (Fig. 3),
one of the brightest stars of the early Belfast
Medical School, was in the process ofwriting a
bookwhichsummarisedhisclinicallectureswhen
he died suddenly of tuberculosis in 1856 at the
ageof42. Thebook waspublishedposthumously
by his colleagues as "The interpretation of
symptoms and signs".2 In this he states "urine
containing sugaris seen only in cases ofdiabetes
. .. the characteristic taste ofthe urine is also an
excellent test". Many years later, in 1923, the
yearthatinsulinfirstbecameavailableforclinical
use, the academic interest in the diagnosis of
diabetes in Belfast had changed somewhat.
Professor James A Lindsay (Fig. 3) was more
concerned in the possibility that the Belfast
medical graduate might miss the diagnosis and
pointed out a number of potential errors - "the
urine may not be abundant, sugar may be
temporarily absent, thirst and wasting may be
unnoticed, the firstsymptoms may relate to eyes,
skin or nervous system". Professor Lindsay's
concernwouldnotbeinappropriateinthepresent
eraofclinicalgovernance. He was well known to
the medical students ofhisday forhis small book
"Medical axioms, aphorisms and clinical
medicine.made bynotknowing, there.'ar te
mitksmd bynotloi g" istil'ver reevn
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today.3 There is aneedforaProfessorofClinical
Medicinetoactas afocusforeducation aswellas
forresearch anditis everyone'shope atthis time
in the Belfast Medical School that a suitable
person to fill that post will soon be identified.
Dr Jack Smyth was the first doctor in Belfast to
specialise in diabetes mellitus. His background
was originally in clinical biochemistry and this
made itpossible forhim to obtain accurateblood
glucose measurements through the clinical
biochemical laboratory atthis hospital.4 In those
days much of the clinical practice ofphysicians
took place in their private consulting rooms and
Dr Smyth lived at 23 University Square. I have
found a letter from Dr Smyth to my father Dr
RobertHaddeninPortadowndated25April 1944
givinganexactmethodofcarryingouta50goral
glucose tolerance test at home. This shows that
shared care for diabetes between family practice
and hospital consulting practice was possible in
thosedays,anditisalsoprobablethatthisglucose
tolerance test was actually carried out in early
pregnancy on this particular patient. It was Dr
Smyth who was responsible for encouraging his
patient Sir George E Clark to leave a sum of
£10,000 specifically to build a metabolic unit at
theRoyalVictoriaHospital. This unitwasfinally
opened on 7 June 1957 by Professor Charles
Best, one of the discoverers of insulin from
Toronto (Fig. 4). The building was built by the
old established firm of H & J Martin who are
currently employed jointly in building the new
Royal Victoria Hospital, which will open this
year. It was then and probably still is the only
purposebuiltunitforendocrinologyanddiabetes
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intheseislandscontainingthebeds,thespecialist
and paramedical facilities, the education centre
for diabetes and endocrinology, and the clinical
and secretarial offices for the staff in the one
building. Originally the metabolic outpatient
clinics took place in this building but these were
moved with the building of the new outpatient
centre in 1967 to the other side of the hospital,
which has always been an inconvenience for our
medical and nursing staffas well as ourpatients.
It has been my privilege to work in this building
for the past 40 years. It opened while I was a
medical student and it will close shortly before
my retirement.S
n... ,. _.W..
Fig S. BiochemistryDepartment, theQueen'sUniversity
ofBelfast, 1956, seen through the archway (now
replaced by the Administration Building).
Biochemistry in 1957 was taught entirely as an
academic, subject in the very small university
department of biochemistry by Professor D C
Harrison atthebackofthequadrangleinthemain
campus of the university (Fig. 5). Theoretical
biochemistry seemed distant and remote to most
ofus andthelinkbetweenuniversity andhospital
wasextremelytenuous.6DoctorSmyth wasofthe
opinion that the only biochemical knowledge
neededfor amedical student was how to measure
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Fig 6. Professor D A D Montgomery.
measure blood glucose which was a tedious but
exciting method involving Bunsen burners and
testtubes, andvarious differentcolouredliquids.
The ability forpatients to self-monitor their own
capillary blood glucose with a glucose oxidase
striphas totally revolutionised the care ofpeople
withdiabetes, inparticularinpregnancy. In 1975,
in the second edition ofhis textbook on Medical
and Surgical Endocrinology, Professor DAD
Montgomery stated"retrospective studies suggest
there is an increased risk of perinatal death in
children born to mothers who develop clinical
diabetes laterin life andthatbirthweights tendto
be high. The characteristic features of the infant
ofthe diabetic mother are well known. The baby
is big for dates, owing mainly to excessive fat,
but all organs, except the brain, are
disproportionately large. The cause of the fetal
"gigantism" is not known, but it may be that
excess of glucose from the mother induces
hyperplasiaofthe fetalisletcells, andthis inturn
causes fetal hyperinsulinism, excessive
lipogenesis and neonatal hypoglycaemia.
Effective control of the maternal blood sugar
throughout pregnancy prevents these changes,
and results in babies of average weight. An
objection to this hypothesis is that many women
with very mild diabetes, or those with potential
diabetes andnormalglucosetolerance, mayhave
large babies years before their diabetes becomes
manifest. The production of a large baby in a
potential diabetic pregnancy may thus be
geneticallydetermined".7ProfessorMontgomery
had established the academic basis of the
metabolicunitwhichhascontinuedtothepresent
time, andhe sends his apologies thathe is unable
to attend this lecture today (Fig. 6).
The knowledge that babies born to diabetic
mothers could be either large or small had been
identifiedbyDrJorgenPederseninCopenhagen.
Hehadbeenaphysicianinterestedintheoutcome
ofpregnancy in the diabetic mother and wrote a
famous book on this topic.8 In this book is a
photograph of two infants of diabetic women
born on the same day at the Rijkshospital,
Copenhagen(Fig. 7).Onelargefatbabyweighing
4.7 kgs at 38 weeks gestation was born to a
diabetic mother who had not attended the centre
until two days before the baby was born. This
mother's blood glucose was clearly much too
high throughout the pregnancy. The other baby
weighed only 2.05 kgs, born rather earlier at 36
weeks. The mother had attended regularly
throughout the pregnancy but had more
complicated diabetes with pre-eclampsia. Both
large babies and small babies can happen in
relationtodiabeticpregnancy. Theseobservations
andotherselsewhere sparkedanongoinginterest
in hyperglycaemia in pregnancy. In Belgium Dr
J P Hoet, an obstetrician, had started doing 50 g
.... ~~ ~~ ~~ ~~ ~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~.......
Fig 7. Tw baie bont ibtcmtesih
Rijkshospital Copenhagen 1956 (reproduced
fo reeec 8)
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glucose tolerance tests in pregnancy afterWorld
War 2.9 Following his visit to Boston, USA, a
large prospective study of the effect of
hyperglycaemiaduringpregnancyonthemother,
and inparticular on the chance ofherdeveloping
permanent diabetes, was established by Dr John
O'Sullivan at the Boston Lying-in Hospital and
published in 1964.10 This producedthe majorUS
criteria for the diagnosis of gestational diabetes
which still stand to the present day, based on a
50 gglucoseloadforscreeningplus asecond 100
gloadfordiagnosis.InBelfast,DrGrahamHarley
and I had started glucose tolerance testing in
pregnancy in 1962 as part ofmy MD thesis. My
hypothesis at that time was that the big baby of
the diabetic motherwas in some way attributable
to excess growth hormone secretion in response
to hyperglycaemia in pregnancy. This was not a
particularly robust hypothesis and I was never
able to prove it, but I did learn a great deal about
glucose tolerance tests in pregnancy, which
interest has continued to the present day.11
I was awarded an RVH Research Fellowship of
about £1,000 per annum (there were never more
than two or three research fellows at the same
time in those years). I was able to collect human
pituitaryglands fromautopsies carriedoutbythe
Department of Pathology and to extract human
pituitary growthhormone fromthem. Ultimately
it was possible to obtain further human pituitary
growthhormonefromthecombinedUKcollection
of pituitaries and to use this for treatment of
growth hormone deficient children with very
encouraging results in over 40 cases. The
possibility thatevenoneofthesehumanpituitary
glands might have been carrying the then
unrecognisedCreutzfeld-Jakob diseasepriondid
not become apparent until about 20 years later. I
am glad to say that none ofthese patients treated
in Belfast for growth hormone deficiency have
thus far developed this fatal condition and they
remainundercounsellingandlong-termendocrine
supervision. 2
With this incomplete knowledge about growth
hormone and its immunoassay, and some
continued interest in glucose tolerance tests in
pregnancy I proceeded to the Johns Hopkins
Hospital, Baltimore, Maryland, USA, to work
with Dr Samuel PAsperwho was atthattime the
seniorendocrinologist(Fig. 8). DrandMrsAsper
weremostkindtomeandtookmeintotheirhome
for some time in much the same tradition as Dr
and Mrs Osler had offered the latchkey of their
..........
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Fig 8. Dr andMrs Samuel PAsper, Baltimore, 1964 and
the Johns Hopkins Hospital, Baltimore, USA.
BaltimorehousetotheyoungDrHarveyCushing
in 1920. Dr Asper was an expert in thyroid
disorders and subsequently became Visiting
Professor attheAmericanUniversity ofBeirutin
theLebanonwherehe wasinchargeofthehospital
during the civil strife and riots in that city. He
gavetheScott-HeronLectureattheRoyalVictoria
Hospital in 1977 and related his experiences in
Beirut, which were much more alarming and
dangerous than any of us had been exposed to
during the Belfast troubles. While at the Johns
HopkinsHospital I was askedto attend ameeting
for Fulbright Fellows to meet President John F
Kennedy in the Rose Garden at the WhiteHouse,
shortly before his assassination. I remember
President Kennedy's address to the visiting
fellows. He most politely thanked us forcoming
to his country and forbringing ourknowledge so
Fi 9. Prsdn Joh F Kend adrsig_ubih
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that they might benefit. I am sure we all felt that
the knowledge was travelling in the reverse
direction to our own benefit (Fig. 9).
At the Johns Hopkins Hospital I collaborated
with Dr Thaddeus Prout who had developed an
ingenious method of demonstrating binding
proteins in normal human serum using
radioiodinated hormones and jointly we
demonstrated for the first time that there was a
growthhormonebindingproteininnormalhuman
serum. I presented this to the Annual Meeting of
the Endocrine Society at Atlantic City, New
Jersey, and met with considerable opposition
fromamemberoftheaudience, whomountedthe
platform and pronounced that my work was
wrong. I only found out later that this was Dr
SolomonBersonwhoatthattimewithDrRosalyn
Yalow had developed a radioimmunoassay for
human growthhormone, which wouldhavebeen
under some theoretical suspicion if a growth
hormone binding protein actually existed in
normalhuman serum.13Ithastakenover30years
for this argument to be resolved. It is now clear
that growth hormone can be measured in normal
humanserumusinganadditionalstronglybinding
gamma globulin antibody, butthatthere is also a
lessstronglyboundnormalserumbindingprotein.
This was finally demonstrated by Dr Gerard
Baumann at Northwestern University, Chicago
in 1986.1' It is interesting and perhaps salutory
thatastheMedline computerised database onthe
Internetdoesnotextendbackwardsintimebefore
1966nomentioniscurrentlymadeoftheoriginal
discovery of the binding protein in 1964 (Fig.
10).
WhenIreturnedtoBelfastIfoundthattheoriginal
protocol for 50 g glucose tolerance tests in
pregnancy had been continued underDr Graham
Harley's supervision at the Royal Maternity
.-Jm " *. ' ll
Fig JO. The growth hormone binding protein in human
serumidentifiedbyradioimmuno-electrophoresis
in 1964, and again by selective chromatography
in 1986 (reproduced from references 13 and 14).
Hospitalandsoontherewereaverylargenumber
of glucose tolerance tests which we analysed in
many ways to assess the relation of maternal
hyperglycaemia to the fetal result.15 Several
papers were published but the matter remained
uncertain and we were not able to demonstrate
strong relationships between the size ofthebaby
and the maternal blood glucose. It eventually
became clear that this is because the prevalence
of gestational diabetes in Belfast is much less
than in other parts of the world. Further
developments of the glucose tolerance test
including a standard breakfast test have been
subsequently usedbutnonehavebeenpredictive
inBelfastintermsofoutcomeofthepregnancy.16
.
Fig 11 A severely malnourished marasmic infant at the
MRC Infantile Malnutrition Research Unit,
Kampala, Uganda -on admission and after
refeeding (1966).
After a year or so back in Belfast I was met one
morning on the RVH main corridor by the then
Professor ofMedicine, Professor G M Bull, who
asked me what I was doing. I told him I was
interestedinhyperglycaemiainpregnancyandin
hypoglycaemiaintheinfantsofdiabeticmothers.
He replied that I should go at once to Uganda
wheretheMedicalResearchCouncilwerelooking
for a clinical investigator to study the
hypoglycaemia that was thought to occur in the
malnourished children with marasmus and
kwashiorkor in that country. As Professor Bull
was amember oftheTropical Medicine Board of
the Medical Research Council it was a matter of
only afew weeksbefore Ifoundmyselfcalledfor
intevie at Park Cresce..............nt in Lodo, h
heduatr of th Meia Reeac Concl
an _ey ailydsathdt th Medca
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ResearchCouncilInfantileMalnutritionResearch
Unit at Mulago Hospital, Makerere University,
Kampala, Uganda. I have discussed my findings
there elsewhere, suffice to say that there was
evidence of insulin resistance in the protein
deficient children with high serum insulin and
low serum growth hormone levels which did
relatetothedegreeoffatretention (Fig. 11). This
wasentirelyrelatedtotheirproteindeficientdiet,
inthefaceofarelativesufficiencyofcarbohydrate
comingfromthebananastapleinthatcountry.17 18
The MRC unitinKampalawastechnicallyunder
the control of Professor R A McCance, the
ProfessorofExperimentalMedicineinCambridge
at that time. He encouraged me to return to
Cambridge bringing blood specimens for
measurement of insulin and growth hormone
withmefromthebabies. ProfessorMcCancehad
been undertaking parallel experiments with a
group of undernourished pigs at a farm outside
Cambridge andthepictureofthethreepigs ofthe
same age is now famous - one pig, very small,
being severely energy restricted, one pig of
mediumsizebutpale,puffyandlethargic, having
had sufficient carbohydrate but insufficient
protein it its diet, and the third pig having had
normal mash and having grown to normal size.
These animal studies, which were backed up by
further studies on smaller animals such as rats
andguineapigs, confirmedthatnutritional status
had aprofoundeffectongrowthinearly life, and
it is now clear that growth in the fetal period is
equally dependent on a proper nutritional
balance.19 20AtthattimeIwastheseniorregistrar
'.4
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Fig 12. Professor R A McCance (lying on right)
phtgahn the pig age on yea oldth
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in endocrinology at the old Addenbrooke's
Hospital in Cambridge. I think I had only one
patient and most of my time was spent hearing
about the Professor's pigs and other animal
interests, to saynothingofhis wellknownracing
bicycle (Fig. 12).
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and DRH in the Metabolic Outpatient Clinic
(1983).
AfterProfessorMontgomery'sretirementin 1980,
Dr Weaver and I werejoined on the staff of the
metabolic unit by Dr Laurence Kennedy and Dr
Brew Atkinson (Fig. 13). At that time a main
interest in the metabolic unit was the
epidemiological study of patients with Type 2
diabetes. After a number ofretrospective studies
wehadembarkedon aprospectivenaturalhistory
study of the long-term survival ofpatients with
this type ofdiabetes which became known as the
Belfast Diet Study.1 This has achieved a
considerable degree ofinternational recognition
by the demonstration that with careful and even
rigorous dietetic advice and follow-up under the
supervision ofMissAnneWilson andherdietetic
colleagues it was possible for a large group of
newly dinosnt edl patients with Type 2 diabetes
meltuis tyeofdibecotrled byic dietamonlyn (Fig 14).
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Natural History ofDiabetes Presenting Age 40-69 Years
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Fig 14. Six year analysis of the Belfast Diet Study
(Reference 22).
remainedexactlythe sameaverageweightforthe
following six years. The fasting blood glucose
whichhadfalleninthefirstthreemonthsfromthe
initial diagnostic mean level of 11 mmols/l to
about 8 mmols/l didnot,however, showthe same
steady level oflongterm control and there was a
slow inexorable rise during the following years.
There was no change in serum cholesterol and
our simple measurement of dietary adherence
alsodidnotrevealanysignificantalteration. This
study and its subsequent extension to 10 years
hasbecomeknownas"TheBelfastBloodGlucose
Phenomenon". The fasting plasma glucose in
Type2diabetes mellitustreatedondietonlyrises
steadily, in spite of good control of weight and
good dietetic adherence, by 0.3 mmols/1 per
year. This means thatover 10 years itwill riseby
3.0 mmols/1. Further studies in the Metabolic
Unit suggested that this was largely due to the
gradual failure of the beta cells of the pancreas
although there is still reasonable debate that it is
also due to increasing insulin resistance with the
passage oftime.23
After completing this study wejoined the much
larger United Kingdom Prospective Diabetes
Study which had been initiated by Dr Robert
Turner at Oxford. This study enrolled over 5,000
newly diagnosed Type 2 diabetic patients and
followed their progress for 15 years. It
subsequently became clear that these patients
also showed the initial fall of blood glucose on
intensive control but that there was a steady
inexorable rise atabout0.3 mmol/l peryearover
the next 15 years. This is demonstrated by the
HbAlc data which shows that both on
conventional and on intensive treatment this
..
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Diabetes Study (Reference 24).
progressive rise in blood glucose took place 24
(Fig. 15). Thereisfurtherevidencethatthisisdue
to a combination of both beta cell failure and
insulin resistance. Sadly Dr Turner died in 1999
shortly after the important results of the study
had been published.2 We in Belfast recognise
that 10% of the patients in this large study came
from Belfast, both at theRoyal VictoriaHospital
and the Belfast City Hospital, and the further
follow-up ofthe surviving patients will continue
for some years to come. A further important
outcome of the United Kingdom Prospective
Diabetes Study was the recognition that blood
pressure isjust as important as blood glucose in
thelong-term survival ofthesepatients. Both the
updated mean systolic blood pressure and the
Any diabetes related endpoilnt ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~...o......................::
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updatedmeanglycosylatedhaemoglobin(HbA1c)
are separately stepwise associated with the
incidence of any diabetes related endpoint, but
when both high blood pressure and high blood
glucose occurtogethertheeffects arecumulative
(Fig. 16). This study has initiated amajorchange
in the approach to the management of Type 2
diabetes, not only in searching for better control
of blood glucose but also in clarifying the
importance of control of blood pressure and of
blood lipids. Further important research into the
associationofinsulinresistanceandhypertension
hasbeencarriedoutbyDrPMBell andanumber
of research fellows at the Metabolic Unit using
theglucoseclamptechnique.TheUnitedKingdom
ProspectiveDiabetes Studywasoneofthefirstin
which nursing research played an important
independent role and the pioneer work ofNurse
Netta Webb andher nursing colleagues has been
widely respected throughout the study.25
These studies in the genesis ofinsulin resistance
and beta-cell failure in Type 2 diabetes were
taking place at the same time as the ongoing
studies of glucose tolerance in pregnancy. Dr
Ralph Roberts at the Royal Maternity Hospital
had initiated investigation of the association of
insulin sensitivity with pregnancy induced
hypertension, using adifferent "minimal model"
techniqueforassessinginsulinresponsetoglucose
stimulation and had suggested that pregnancy
induced hypertension was in many ways
analogous to pregnancy induced hyper-
glycaemia.26ThecloseproximityoftheMetabolic
Unit to the Royal Maternity Hospital facilitated
thesestudies, andprovidedasuitablebackground
to the development of the hyperglycaemia and
adverse pregnancy outcome concept. Professor
Graham Harley had continued to encourage our
interestsintheobstetricalaspectsofcarbohydrate
metabolismandhisplaceasobstetricianincharge
of diabetic pregnancy at the regional centre was
takenby DrA I Traub. The outstanding record of
improvement in perinatal mortality at the Royal
Maternity Hospital over the past 60 years has
been internationally recognised, with a fall in
perinatal mortality fromover30% ofpregnancies
in 1940 to about6% inthe year2000.27 However
this still is greater than the overall hospital
mortality, and the present day diabetic mother is
still faced with afourfold greaterriskto herbaby
than a nondiabetic mother. Perinatal mortality
over the past 10 years in the whole of Northern
Ireland was 37/1000 for diabetic pregnancies
compared to only 9/1000 overal 1.28 It is our aim
further to reduce this risk of pregnancy to the
diabetic mother. Arecentpregnancy outcomefor
adiabetic motherwho haddifficulty inobtaining
good blood glucose control in early pregnancy
will illustrate the point. Her baby was born with
onlytwochambers intheheart, oneventricle and
oneatrium,butaftercardiac surgeryhas survived
totheageoffiveormore. Hewasalsounfortunate
enoughtobe affectedby anothercomplication of
maternal hyperglycaemia known as sacral
dysgenesis which meant that his sacrum and
bladder did not develop properly at the right
embryological time and he had to remain in
nappies up to the age of four years (Fig. 17).
Similarcongenitalabnormalitiescanbeproduced
inexperimental rats wherethe motheris exposed
to ahighbloodsugarforarelatively shorttime in
the early stages ofpregnancy and there seems to
beawindowintimewhentheteratologicaleffects
of a high blood glucose are expressed.29
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WHERE ARE WE NOW?
The Pedersen hypothesis has now been amply
established,withthedemonstrationthatdecreased
maternal insulin sensitivity produces impaired
maternalglucosemetabolismresultinginmaternal
hyperglycaemia, whichpassesdirectlyacross the
placenta to cause fetal hyperglycaemia; the fetus
howeverisnotdiabetic andhasnormalpancreatic
beta cells after 20 weeks and therefore is able to
produce increased insulin in response to the high
bloodglucose (Fig. 18). This increased insulin in
association with normal nutrition results in
increased fetal fat deposition and macrosomia.
This hypothesis has been proved to be true in a
numberofexperimentalmodelsandisnowwidely
accepted as the explanation forthe occurrence of
at least some cases of macrosomia in diabetic
pregnancy. However, large babies continue to be
born even when the blood glucose appears to be
relatively normal.
Theconceptofgestational diabeteshasnowbeen
definedas "glucoseintolerance withonsetorfirst
recognition during pregnaney".30 There is good
evidence that the prevalence of gestational
diabetes varies very considerably in different
parts of the world with a 100-fold difference
demonstrated in studies between Newcastle-on-
Tyne and Belfast where the prevalence is low,
and in cities like Los Angeles and San Antonio,
USA, which arebothclosetotheMexicanborder
andtowhichmanyMexican-Latinomotherscome
during their pregnancy, where the prevalence is
one in tenpregnancies ormore.3" The reasons for
this enormous difference in the prevalence of
gestational diabeteshas notbeenfullyexplained,
neither has the increasing incidence in different
ethnic groups coming from different parts ofthe
world to live in the same place, such as the
Pedersen Hypothesis
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Fig 18. The Pedersen Hypothesis.
increasing prevalence shown in studies in St
Mary's Hospital, London, or in Melbourne,
Australiaoverarelatively shorttime. There are a
number of reasons why gestational diabetes is
different in differentparts ofthe worldincluding
differentprevalences ofType2diabetes,different
diagnostic criteria, different screening methods
for hyperglycaemia in pregnancy and different
genetic backgrounds in different ethnic groups.
The reason for the apparently dramatic increase
in prevalence over relatively short periods of
time is widely thoughttoberelatedto changes in
thefoodwhichiseatenamongstthepopulationin
rapidly developing countries. There is intriguing
evidencethattheprevalenceofdiabetes wasvery
low in Ireland before the potato famine in 1840
butthattherewasarapidincreaseassociatedwith
the increasing living standards of the general
population following the famine, although that
was associated with a change from the previous
very healthy dietwhichhadconsisted ofup to 10
pounds ofpotatoes and apint ofmilkper day for
aworking man (90% ofthe energy carbohydrate,
5%proteinand5%fat).32Whetherdietarychanges
explain all of the rise in gestational diabetes
remains uncertain but it is undoubtedly a major
public health problem in the developing as well
as the developed world.33 34
The careful studies ofO'Sullivan inBoston have
proved that gestational diabetes predicts
subsequent Type 2 diabetes in the mother.35 A
furtherquestion, however, is whethergestational
diabetes poses a risk to the baby. O'Sullivan's
studies had suggested an increased perinatal
mortality in babies born to mothers with
gestationaldiabetes(6.4%versus 1.5%inacontrol
group). Hisdefinitionofgestationaldiabetes was
related to the original lOOg three hour glucose
tolerance test which has long been used by
American obstetricians.36 Morerecent studies by
thegroupattheUS NationalInstituteofHealthin
Phoenix, Arizona, studying the Pima Indians,
showed similar results related to a 75 g glucose
tolerance test which has been much more widely
used in other parts of the world including
Europe.37'38 In Australia the large experience of
Beischer was conducted inrelation to a 50 g oral
glucose tolerance test which he had learnt to use
when working as an obstetric registrar in Belfast
inthelate 1950's.39FormanyyearstheAustralian
continent continued to use the 50 g GTT. There
were thus considerable difficulties in comparing
the results from one country to another.
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Thisdifficultyandotherconcerns aboutthelong-
term outcome of the infants of gestationally
diabetic mothers led a group of interested
physicians, obstetricians and paediatricians to
meet at the invitation of both the US National
InstituteofChildHealthandHumanDevelopment
and the US National Institute of Diabetes,
DigestiveandKidneyDiseases, ataninternational
workshop on Adverse Perinatal Outcomes of
Gestational Diabetes in 1992, at the National
Institute of Health, Bethesda, Maryland, USA.
At that meeting we determined to make a joint
application for a study of the outcome of
pregnancy inthemilderhyperglycaemic mother,
and this eventually developed into the HAPO
hypothesis (Hyperglycaernia and Adverse
PregnancyOutcome). Itwasrecognisedthatthere
was considerable controversy in the field, with
concern that the results of blood glucose
measurements were confounded by maternal
obesity, increasing maternal age and maternal
hypertension,40,41 and also that there might be
bias expressed by the care giver in relation to
suspected but unproven risk associated with
allegedhyperglycaemiathatmight stillbewithin
anormalrange.42'41'4Atthe sametimethere was
increasingconcernfromparts oftheworldwhere
gestationaldiabeteswascommonthatevenlesser
degrees of hyperglycaemia than those currently
recognised as gestational diabetes were causing
effects on the baby which were being passed on
tothenextgeneration. Therewasthusconflicting
advice on the one hand to increase screening
procedures and to lower diagnostic criteria and
on the other hand to stop all efforts to identify
maternal hyper-glycaemia unless more data on
morbidity in the offspring of glucose intolerant
mothers was available.41'46
At aboutthattime the studies ofProfessor David
Barker and his colleagues in Southampton
University, which have become known as the
Barker hypothesis, were being published. These
studies initially comprised long-term
retrospective follow-up ofpopulations ofbabies
born in several well described parts of England
where it was possible to identify those same
babies 50 or more years later. It was found that
babies who were small at birth were very much
more likely to have developed Type 2 diabetes
andhypertension 50 or60 years laterandthatthe
diabetes and hypertension were associated with
insulin resistance.47'48 The Barker hypothesis
was thatthese small babies were due to placental
Barker Hypothesis
Maternal malnutrition
Placental insufficiency
Small babies
Subsequent insulin resistance
Type 2 diabetes/hypertension
Fig 19. The Barker Hypothesis.
insufficiency related to some form of maternal
malnutrition. This has led to a debate on the
merits of the so-called "thrifty genotype"
hypothesis and the "thrifty phenotype"
hypothesis. The former had been proposed 30
years ago,47 based on the concept that a
hypotheticaldiabetesgenewouldendowanability
to survive intimeoffamine, asthebloodglucose
wouldbemaintainedforlongerataleveltoallow
normal physiological function of muscle and
brain, ratherthan suffering fromhypoglycaemia.
This idea had some credence in the unusually
highrecentprevalenceofdiabetes insomenative
American tribes who had survived in apparent
good health without diabetes during successive
generationsofpresumptivenutritionaldeficiency
whentheywereactivelydefendingtheirterritory,
onlyto show adramatic increase inthe incidence
of diabetes when they became sedentary and
were exposed to nutritional excess under a U.S.
government settlement in the safety ofan Indian
Reservation. The thrifty phenotype hypothesis,
ontheotherhand,emphasisedthatType2diabetic
adult had achieved a physiological adaptation
involving insulin resistance in a number of
metabolicprocesses,followingonanearlyperiod
of nutritional deficiency which could be both
intrauterine and early postnatal: this adaptation
led to obesity, hyperglycaemia, hyperlipidaemia
and hypertension.48
The very extensive epidemiological database
available on the Pima Indian population in
Arizona, USA, allowed further investigation of
these transgenerational effects. Dr David
McCance and colleagues were able to show in
that population where diabetes affects up to 50
per cent of adults, that there was a greater,
prevalenceofadultdiabeteswhentheindividuals
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birthweighthadbeeneither smallerthanaverage
(less than 2.5 kg) or greater than average (more
than4.5 kg),thanwhenbirthweightwasbetween
thesefigures.49This"U-shaped"curveofdiabetes
prevalence held for adults aged 20-39, and led to
a third concept of the "surviving small baby
genotype". Was the small-for-dates baby which
had been identified in the Barker hypothesis
carrying a gene for diabetes or diabetes
susceptibility which both accounted for its small
size atbirthanditslaterdiabetes?This wouldnot
necessarily be the same pathophysiological
process which accounted for the increased
diabetes risk of the large-for-dates baby, where
theprevious Pedersen hypothesis seemedto give
an adequate explanation (Fig. 20).
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Fig 20. The "surviving small baby" genotype (reference
49). The diagrams show that the prevalence of
diabetes in adults in fourage groups from 20 to 35
years, each showed a U shaped curve with more
becoming diabetic for birth weights less than 2.5
kg and more than 4.5 kg than for the intervening
birth weights.
An extension ofthis thirdhypothesis was offered
by Hattersley and Tooke50 in an elegant
demonstration ofthe birth weight distribution in
a small number58 of off-spring born to mothers
knowntohave anunusualformofType2diabetes
due to a recognised genetic mutation affecting
the glucokinase enzyme. When neither mother
nor fetus had the mutation the birth weight was
normal, as it was when both mother and baby
were affected. When the mother was affected
(and hyperglycaemic) but the baby was normal
(did not have the mutation) the birth weight was
high, presumably due to fetal hyperglycaemia
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Figure 3: Birthvveight centile distribution in 58
offspring of parents with glucokinase mutations
according to maternal and fetal genotype
Fig 21. Birth weight centles in MODY families with
glucokinasemutations,according tomaternaland
fetal genotype (Reference 50).
gene the birth weight was low, presumably
becausethedevelopingfetuscouldnotmetabolise
even the normal glucose available to it (Fig. 21).
Hattersley has indicated the two alternative
explanations for the association of small thin
babies with insulin resistance, Type 2 diabetes
and ischaemic heart disease - either an effect of
poor intrauterine environment, or of a gene
influencing insulin resistance. Each of these
mechanisms would result in small thin babies,
and each would account for insulin resistance
which would ultimately lead to the long-term
problems of the adult.
There hadbeencareful studies offetalpancreatic
beta cell function in gestational diabetes in a
number of centres, and there is no doubt that in
this condition the fetal insulin is high enough to
affect the outcome. Mean amniotic fluid insulin
in 52 gestational diabetic pregnancies was 15.0
mU/l compared to 7.4 mU/l in 27 control
pregnancies, and similar differences were found
inumbilicalcordc-peptidelevels atbirth There
is also evidence that both childhood 2and adult
obesity13in the offspring is related to gestational
diabetes in the mother.
These concepts have also been confirmed in
studies of the development of adult diabetes in
the next generation. The role of the intrauterine
environmenthasbeendemonstrated inproducing
congenital scetibilityratodTyeta 2diabtyetsith
Pima1.Bit Indians5 aendle in adOlesen ofspringe oft
gettinlucdinabeti motheros,acringChcao maenan
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The development of a large-for-dates or
macrosomic baby related to increased maternal
bloodglucosehasbeenrecognisedfromtheearly
studies ofdiabetes inpregnancy. Moreextensive
epidemiological reports fromthePimaIndians,37
Italy56andtheLatinopopulationofLosAngeless7
have confirmed this concept in mothers with
gestational diabetes. There is also evidence that
treatment of the mother with insulin during
pregnancy will prevent this macrosomia. In an
early randomised clinical trial of prophylactic
insulin in 1966 O'Sullivan showed that whereas
13.1% ofbabies born to 306 gestational diabetic
mothersweighedmorethan9lbatbirth,compared
to3.7% of324controlnormoglycaemic mothers,
administration of a standard dose of 10 units of
isophane insulin in later pregnancy significantly
reduced the number of babies weighing more
than9lbto4.3%of305pregnancies.58Subsequent
clinical studies have supported this study,
althoughthereis stillconsiderableuncertainty as
to when and how best to use insulin in this
situation.59
Thepresentconceptoftransgenerationaldiabetes,
whichisrelatedinparttointrauterinemalnutrition
and in part to overnutrition, with or without the
expression ofagenepromoting hyperglycaemia,
and resulting in either a small baby or a large
baby which has resistance to insulin action, is
reasonably well accepted (Fig. 22). These
theoreticalconceptsoftheeffectsofcarbohydrate
intolerance on maternal fetal outcome will only
be of public health importance if they represent
an increasing problem even at lower levels of
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Fig 22. Transgenerational diabetes: the possible roles of
under-nutrition and over-nutrition in producing a
small or a large baby, related to insulin resistance
and subsequent diabetes and hypertension.
blood glucose than those currently diagnosed as
gestational diabetes. The Toronto tri-hospital
project(whichusedthestandardNorthAmerican
100 g OGTT) studied 3,600 women who were
knownnottohavegestationaldiabetesandshowed
that even a relatively mild degree of increasing
carbohydrateintolerancewithinthenormalrange
was associated withmacrosomia, pre-eclampsia,
increased Caesarean section rate and a longer
hospital stay.61 The stagehasthusbeen setforthe
HAPO studytoinvestigatethis matterby alarger
studyusing astandardised75 gglucosetolerance
test in many parts of the world. This will allow
further assessment of the relative roles of the
Pedersen hypothesis of fetal overnutrition and
the Barker hypothesis of fetal undernutrition on
thesubsequentdevelopmentofinsulinresistance
in the baby, and the longerterm risks ofdiabetes
and hypertension in the offspring as they grow
up. The overall concept that "diabetes begets
diabetes" is gradually becoming accepted.
WHERE ARE WE GOING?
Charles Darwin in his work in 1859 "On the
origin ofspecies by means ofnatural selection or
thepreservation offavouredraces inthe struggle
for life" is generally accepted as the founder of
theconceptofgeneticsasthemeansofevolution.62
Whether genetic mechanisms are sufficient to
explain theratherrapidchanges inprevalence of
diabetesmellitusremainsuncertain. Theprevious
andlargelydiscreditedtheoriesofLamarck(1801)
on the inheritance of acquired characteristics
might be thought to be applicable to the
transplacental passage of hyperglycaemia from
mother to baby but that concept would not be
sufficient to explain the famous problem ofwhy
the giraffe has a long neck.63 Both the
philosophical and practical aspects of mild
disturbances in maternal carbohydrate tolerance
wereinitiallyemphasisedbyDrNorbertFreinkel,
at that time in charge of the research group at
NorthwesternUniversity, Chicago, andhewould
certainly have approved of the subsequent
application for a major international grant to
study this problem."M The first application was
made by the Steering Committee in 1995 and
after very considerable work and the utilisation
ofa very large amount ofpaper in many parts of
the world, was finally successful at the third
attemptin 1999. Theorganisational details ofthe
study are now available on the Internet.65 The
Steering Committee met again in Chicago in
1999 to finalise the very detailed manual of
C) The Ulster Medical Society, 2001.132 The Ulster Medical Journal
operations which has undergone further
refinement with the passage of time. The total
grants awarded to date include $8.8 million from
the National Institutes of Health supplemented
by $1.5 million from the American Diabetes
Association and £102,000 from Diabetes UK. A
smaller grant of36,000 Ecu's had been awarded
by the European Community for portions of the
workjudged to show the principle ofsubsidiaity
within Europe but unfortunately even that small
grant was withdrawn because of our failure to
start the study within their strict time limit. We
hope that some further generosity from the
European Community will still be available.
TheaimoftheHAPOstudyistoexamineglucose
tolerance in a large multinational multi-cultural
ethnically diverse cohort of women in the third
trimester of pregnancy with medical caregivers
"blinded" to blood glucose data (except when
predefined criteria are met). There will be 16
centres with a common protocol and data
collection, a uniform training ofpersonnel and a
centrallaboratory. Thiswillderiveinternationally
acceptable criteria for gestational diabetes
mellitus. The field centres are at Bangkok,
Barbados, Beersheba, Belfast, Bellflower (Los
Angeles), Brisbane, Chicago, Cleveland, Hong
Kong, Manchester (UK), Newcastle (Australia),
Petah-Tiqva (Israel), Providence (USA),
Singapore, Toronto and Utrecht. Other centres
were considered by the Steering Committee and
itwaswithconsiderablereluctancethatwehadto
reduce to the final 16 in order to satisfy the very
strict obstetrical criteria laid down by the US
National Institutes of Health. This is not to say
thatthefindings oftheHAPO study will notbeof
equal importance in all parts ofthe world and in
all obstetrical communities.
Thecentrallaboratory forthewholestudywillbe
at the Royal Victoria Hospital under the
supervision ofProfessorElizabethTrimble, with
blood samples from 25,000 women coming in
over the next two years for measurement of
glucose (Mr Selby Nesbitt and Mr Mike Smye),
C-peptideandinsulin(MrBrianSheridanandMr
Colin Burgess) and glycosylated haemoglobin
(HbA1c)(ProfessorTLappinandMissGeraldine
Savage). The laboratory has been inspected to a
veryhighdegreebytheUS National Institutes of
Health and found to be satisfactory in every
respect. Therewillbeaveryconsiderable amount
ofworkto complete the measurement ofall these
samples within the time line. The clinical co-
ordination centre and data interpretation centre
will be at Northwestern University in Chicago
and data from the central laboratory will be
transferred instantaneously by e-mail to the
computersuiteinChicagoforstatistical analysis.
An important ethical issue is the blinding of the
obstetricians and midwives (caregivers) to the
results ofthe glucose tolerance test, unless these
exceeded those levels which are currently
diagnosticofgestationaldiabetes. Thisisinorder
to provide unbiased information, without
intervention following the GTT, on any
relationship between the outcome of pregnancy
andthe maternal bloodglucose. The whole study
including this aspect is carefully explained to all
mothers at time of enrolment and detailed
informed consent is obtained by the HAPO
midwives. We have already found very many
mothersattendingtheRoyalMaternityandJubilee
maternity servicetobeenthusiastic aboutjoining
this study and they show considerable interest in
whathappens,bothtothemselves andtothestudy
as a whole.
The primary outcomes will be the occurrence of
a Caesarean section, of fetal macrosomia or
obesity measured by skin fold callipers, of
neonatal hypoglycaemia measured one to two
hours after birth by heel prick analysis, and of
fetalhyperinsulinaemiameasuredbyacordblood
C-peptideassay.Secondaryoutcomeswillinclude
neonatal polycythaemia, hyperbilirubinaemia,
respiratorydistressandtheoccurrenceofshoulder
dystociaoranybirthinjury. Oneinitial studywas
necessarytodocumenttheeffectofearlyfeeding
ontheneonatalbloodglucoselevel atonehourof
age.66This has alreadybeenpublished indicating
that early breast feeding as sometimes practised
at the present time does not affect the baby's
capillary blood glucose levelbetween oneto two
hours, and is therefore acceptable ifit is the wish
ofthemotherwithinthestudyprotocol. Anumber
ofotherancillary studieshavenowbeenapproved
bytheSteeringCommittee.Theseincludeafurther
study of matemal blood pressure and insulin
responseswhichwillallowassessmentoftherole
of insulin resistance in both pre-eclampsia and
gestational hypertension in this large group of
pregnancies. At the same time, and after specific
informed consent, blood specimens from mother
and baby will be kept forDNA analysis allowing
further investigation of possible genetic
determinants of Type 2 diabetes and of fetal
weight. A specific study in the Asia and Pacific
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region will investigate furtherpossible causes of
neonatal hypoglycaemia unrelated to
hyperinsulinism. The Hong Kong group will
undertake a study of maternal oxidative stress
and its effect on fetal outcome. The Cleveland
Ohio group hope to study a number of more
detailed and more accurate markers of neonatal
total body fat in relation to maternal nutrition.
The Belfast group will study anumber offactors
including maternal thyroid status at the 28 week
timeoftheoralglucosetolerancetest,thegenetic
control of haemoglobin synthesis, maternal
nutritional status by dietary questionnaire, and a
more detailed genetic study including DNA
sampling from the father as well as the mother
and baby which should allow a more searching
assessment of the fetal insulin genetic theories
whichhavebeendiscussedpreviously.TheHAPO
study has already commenced in most of the
centres,aftercarefulinspectionandaccreditation
by the US National Institutes ofHealth to ensure
consistent standards both of obstetrical practice
andneonatalcare. Theconsiderablegrantincome
associated with this study has had a beneficial
effect on the research ratings of the
endocrinological, biochemical and obstetrical
groups at the Royal Group ofHospitals and also
with the Queen's University of Belfast.
Charles Darwin stated "withouthypothesis there
is no useful observation". The HAPO hypothesis
that hyperglycaemia in pregnancy less severe
than overt diabetes mellitus is associated with
increased risk of adverse maternal fetal and
neonatal outcomethatisindependentlyrelatedto
thedegreeofmetabolicdisturbanceremainstobe
proved, but we expect very considerable interest
in the outcome of the study when it is finally
publishedintheyear2004.Therehastraditionally
been an interest in the birth of a big baby and
concern at the birth ofa small baby. The relation
ofboth ofthese events to the consumption of75
g of a glucose drink by the mother at 28 weeks
gestation,andwhetherthemother'sglucoselevels
are connected to the weight of the baby by a
nutritional orby agenetic mechanism, orbyboth
acting in concert, remains uncertain.
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